REGENERON PHARMACEUTICALS, INC. - FORM 10-K - EX-21.1 - SUBSIDIARIES OF REGENERON PHARMACEUTICALS, INC. - February 11, 2016

Attached files

file	filename
EX-3.2 - BY-LAWS, AS AMENDED - REGENERON PHARMACEUTICALS, INC.	regn-ex32x12312015x10k.htm
EX-31.2 - CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A) - REGENERON PHARMACEUTICALS, INC.	regn-ex_312x12312015x10k.htm
EX-23.1 - CONSENT OF PRICEWATERHOUSECOOPERS LLP - REGENERON PHARMACEUTICALS, INC.	regn-ex_231x12312015x10k.htm
EX-31.1 - CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A) - REGENERON PHARMACEUTICALS, INC.	regn-ex_311x12312015x10k.htm
EX-10.2.5 - STOCK OPTION AGREEMENT AND NOTICE OF GRANT (NQ) TO P. ROY VAGELOS - REGENERON PHARMACEUTICALS, INC.	regn-ex_1025x12312015x10k.htm
EX-10.2.6 - STOCK OPTION AGREEMENT AND NOTICE OF GRANT (ISO) TO P. ROY VAGELOS - REGENERON PHARMACEUTICALS, INC.	regn-ex_1026x12312015x10k.htm
EX-10.26.4 - FOURTH AMENDMENT BETWEEN CREDIT SUISSE AND THE REGISTRANT - REGENERON PHARMACEUTICALS, INC.	regn-ex_10264x12312015x10k.htm
EX-10.2.10 - STOCK OPTION AGREEMENT AND NOTICE OF GRANT (NQ) TO NON-EMPLOYEE DIRECTORS - REGENERON PHARMACEUTICALS, INC.	regn-ex_10210x12312015x10k.htm
10-K - 10-K - REGENERON PHARMACEUTICALS, INC.	regn-123115x10k.htm
EX-32 - CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 - REGENERON PHARMACEUTICALS, INC.	regn-ex_32x12312015x10k.htm

Exhibit 21.1

SUBSIDIARIES OF REGENERON PHARMACEUTICALS, INC.



	Name of Subsidiary*		State or Other Jurisdiction of Incorporation or Organization
	Loop Road Holdings LLC		New York
	OSMR Holdings		Bermuda
	OSMR International		Bermuda
	Regeneron Capital International B.V.		The Netherlands
	Regeneron Genetics Center LLC		Delaware
	Regeneron Healthcare Solutions, Inc.		New York
	Regeneron International		Ireland
	Regeneron International Holdings LLC		Delaware
	Regeneron Ireland		Ireland
	Regeneron Ireland Holdings		Ireland
	Regeneron Spain, S.L.U.		Spain
	Regeneron UK Limited		United Kingdom

	_____________
	* Directly or indirectly wholly owned by Regeneron Pharmaceuticals, Inc.